CIK 0001178670 · Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 770602661
- Phone
- (617) 551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-19 | Garg Pushkal EVP Chief R&D | Sale 10b5-1 | −305 | $461.01 | $141K | 20,266 |
| 2025-08-19 | Garg Pushkal EVP Chief R&D | Sale 10b5-1 | −45 | $461.74 | $21K | 20,221 |
| 2025-08-18 | Garg Pushkal EVP Chief R&D | Sale 10b5-1 | −39 | $447.98 | $17K | 23,033 |
| 2025-08-18 | Garg Pushkal EVP Chief R&D | Sale 10b5-1 | −90 | $449.92 | $40K | 22,943 |
| 2025-08-18 | Garg Pushkal EVP Chief R&D | Sale 10b5-1 | −39 | $450.92 | $18K | 22,904 |
| 2025-08-18 | Garg Pushkal EVP Chief R&D | Sale 10b5-1 | −103 | $451.99 | $47K | 22,801 |
| 2025-08-18 | Garg Pushkal EVP Chief R&D | Sale 10b5-1 | −329 | $452.96 | $149K | 22,472 |
| 2025-08-18 | Garg Pushkal EVP Chief R&D | Sale 10b5-1 | −543 | $454.04 | $247K | 21,929 |
| 2025-08-18 | Garg Pushkal EVP Chief R&D | Sale 10b5-1 | −241 | $454.84 | $110K | 21,688 |
| 2025-08-18 | Garg Pushkal EVP Chief R&D | Sale 10b5-1 | −12 | $455.82 | $5K | 21,676 |
| 2025-08-18 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −39 | $447.98 | $17K | 30,823 |
| 2025-08-18 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −90 | $449.92 | $40K | 30,733 |
| 2025-08-18 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −39 | $450.92 | $18K | 30,694 |
| 2025-08-18 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −103 | $451.99 | $47K | 30,591 |
| 2025-08-18 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −329 | $452.96 | $149K | 30,262 |
| 2025-08-18 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −543 | $454.04 | $247K | 29,719 |
| 2025-08-18 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −241 | $454.84 | $110K | 29,478 |
| 2025-08-18 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −12 | $455.82 | $5K | 29,466 |
| 2025-08-18 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −63 | $447.98 | $28K | 52,332 |
| 2025-08-18 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −147 | $449.92 | $66K | 52,185 |
Page 24 of 41 · 816 trades